During this webinar, Nikki Turner and Emma Best will discuss:
- The impact of RSV on the adult population.
- The impact of RSV on the paediatric population.
- NZ epidemiology with a focus on pre and post covid disease burden.
- Vaccine potential - and passive immunity.
As always, we will answer as many questions as possible during this session.
Video
Presenter
Emma Best
Emma is a Paediatric Infectious Diseases specialist at Starship Children’s Health, Te Whatu Ora, a Senior Lecturer at the Department of Paediatrics Child and Youth Health and medical advisor at the Immunisation Advisory Centre in the University of Auckland.
Her clinical and research areas of interest include vaccine preventable diseases, paediatric respiratory infections and appropriate antimicrobial prescribing in children. She has authored over 60 peer-reviewed articles on these topics and a recent book chapter on COVID infections in children. She is an advocate for meningococcal control by vaccination for tamariki in Aotearoa NZ.
Presenter
Nikki Turner
MBCHB MPH DIB OBS DCH MD FRNZCGP FNZCPHM (Hon)
Professor Nikki Turner is an academic General Practitioner and the Medical Director of the Immunisation Advisory Centre, University of Auckland, New Zealand.
Nikki’s interests are in immunisation, respiratory illness, primary and public health care. She resides in Wellington and works part-time as a General Practitioner. Nikki sits on a range of NZ national advisory groups for the government, Ministry of Health and Pharmac focused on clinical and policy advice around vaccine preventable diseases, the immunisation programme and COVID-19.
Academically, Nikki is widely published with over 100 academic publications in the arenas of immunisation, vaccinology, and child health
Supported by an unrestricted educational grant from:
